The paper of Prof. Mario Plebani, which is published in this issue of the Diagnosis, provides an accurate analysis of the changes that have occurred in the last few decades in Laboratory Medicine [1] . This article encompasses a thoughtful selection of the most significant scientific articles published during the period and clearly highlights the starting point, the path followed and the future directions that laboratory professionals should follow to remain at the center of the patient care pathway.
A quick chronological overview of the evolutionary pathway of Laboratory Medicine highlights an alternation of euphoric moments of professional pride with phases of deep prostration and identity crisis.
We are mostly prone to remember only these previous dark periods, focusing on the most negative aspects. However, nothing could be more mistaken, especially because we were an active part of that past. During these periods we have been deeply involved and committed to work according to a systemic organization and to comply with policies of our national healthcare system (NHS), so that the choices were strongly influenced by the context.
We have for long lived the life of "laboratory mice", strongly committed to the strict control of data generated by internal quality controls and external quality assessment, as well as to precision, accuracy, bias and total error, so emphasizing the excellence of our "kingdom". What was happening outside the boundaries of our laboratories was not felt to be our problem. On the other hand, the generation of large volumes of data was perceived as the main target, thus demonstrating the vast potential of the modern generation of automated laboratory instrumentation. Appropriateness was not felt to be a main issue, along with the large waste of reagents often occurring as a result of large orders placed with little interest about the expiration date. Clinical laboratories were mostly out of control, thus making us waver between self-esteem and self-reproach. We had virtually reached a large degree of inefficiency, and synergy with clinicians was not an integral part of our daily activity.
Nevertheless, there were also some positive aspects. At that time we had so much implemented a strategy for statistical control of analytical quality, that it had virtually became a core activity. Through the constant monitoring of the analytical process, we also acknowledged the importance of both pre-analytical and post-analytical variability. Organization management and professional quality certification by external organizations also became unavoidable, thus enormously amplifying ISO certification and professional accreditation. We have hence evolved from a "self-referential laboratory mice", to professionals committed to confrontation, a necessary aspect for enhancing our knowledge.
A darker period then followed. We have been trapped in a vortex of efficiency, and laboratory professionals also become economists. In health management training courses, budget, cash flow and the return of investment, have become essential aspects. We have been warned about the risk of financial waste. Very often, the reply to our requests to introduce new diagnostic tests was mainly focused on its cost. This obviously prompted us to pursue efficiency, alienating us from the main goal of pursuing clinical effectiveness.
Once again we sought to identify the positive aspects, thus transforming negative experiences into valuable perspectives. We realized that competency in cost control (i.e. an essential part of our profession), along with quality control/monitoring throughout all steps of the analytical process, were effective in making laboratory reports more clinically usable (i.e. effectiveness) without impairing system sustainability (i.e. efficiency). Therefore, economic analysis is no more a questionable strategy often used as a punitive instrument by hospital administration for assigning budget.
Nevertheless, the important value of this management tool lies in the fact that the analysis of all the components accounting for the total expenditure (i.e. test volume, technological and human resources, general costs) combined with process analysis not only yields economic efficiency but also can also be considered a measure of efficiency and effectiveness [2] .
The effective-cost analysis methodology can be described as follows: 1. Processes mapping (aimed at objectively reviewing a specific analytical process rather than re-engineering the whole organization); 2. Proper data collection. This is the most challenging phase, as the laboratory information system and the administrative structures of an NHS (e.g. information system, management control, etc.) cannot provide the necessary, appropriately classified, information. 3. Accurate allocation of costs within each analytical process (e.g. hematology, coagulation, core laboratory, etc.).
Elaboration of performance indicators.
This tool management may allow to: a) generate suitable evidence for decision-making during the planning phase (PLAN/DO), accurately collecting all the necessary data. b) collect information in an organized and continuous fashion. The results of the ensuing improvement plans can be measured during the monitoring phase and, when necessary, the appropriate corrective measures can be adopted, based on the principle of continuous improvement (CHECK/ACT). c) transform costs management from a "distorted economy" [3] , which considers the laboratory tests as a "commodity", into instruments which will help to achieve the main target of increasing clinical effectiveness of the entire analytical process.
The value of this approach will consistently increase by using benchmarks between different laboratories, according to well-defined performance indicators. Comparisons will include total costs, cost per tests, technologies, personnel, and can be extended to the entire laboratory activity or limited to specific sectors. These elaborations, based on objective evidence, can be brought to the policymakers and hospital administrators for planning of future financial investments. Finally, competency in methodology enables simulation already while designing the model, the predicted effects on the organization and benchmarking performance data with other national and international laboratories, so producing an index of organizational effectiveness.
This management tool, which is strongly related to efficiency and effectiveness, allows achieving efficiency goals by focusing on appropriate test utilization rather than on the application of scale economy. It also allows carrying out an evidence-based analysis for comparing different organizational models.
The most widespread model is that based on the socalled "HUB and SPOKE" paradigm, encompassing a network of different organizations: a) Large HUBs, in which most of the analytical activity is consolidated within hospitals or in other non-hospital facilities, whilst urgent tests are maintained in SPOKE facilities (i.e. peripheral hospitals). The application of scale economy is challenged by the important financial investments that must be made for technological resources and personnel to ensure care continuity of care, accurate control of all the analytical phases and correct management of urgent tests in SPOKE hospitals. In these organizations, however, epidemiologic and case-mix analyses are easier, thus representing an important step towards better planning of activities and healthcare policies. Guidelines for implementation and monitoring of appropriateness strategy are also facilitated. b) Laboratory networks characterized by activities meeting the needs of reference hospitals, which consolidate some analytical steps to increase the testing volume. This organization, is characterized by medium-sized HUBs in the reference regional hospitals, and SPOKE facilities equipped with point-of-care testing instrumentation, can more easily achieve efficiency targets. Moreover, when the network is appropriately managed, it will be able to perform epidemiologic and case-mix analyses, as well as implementing appropriateness strategy. However, the maintenance of an appropriate volume of activity (i.e. autoimmunity, allergology, special coagulation, molecular biology, microbiology, testing) requires that tests are consolidated somewhere within the network.
The adoption of one of these two models should also encompass an accurate geopolitical analysis. Logistical issues (i.e. transportation of biological samples, delivery times and compliance with storage conditions) and local health planning (i.e. number, type and localization of healthcare facilities and wards) should be carefully considered.
Beside systematic analyses, which are out of the scope of this editorial, but inspired from the valuable article of Prof. Plebani, some important aspects can be highlighted for these two models.
1. Both models need the generation of a network, whose enhanced value is to combine large volumes with flexibility, to setup multidisciplinary teams capable of maintaining a close relationship with clinicians, sharring protocols, technology, controls and experiences in different parts of the network. 2. Consolidation of autoimmunity, allergology, special hemostasis or hematology, molecular biology and microbiology testing needs to be in line with the current status and the future developments of laboratory medicine. Understandably, it seems no longer reasonable to use the concept of "general laboratory with specialized sectors", whilst it is by far more practical to refer to the different diagnostic disciplines. Laboratory professionals with appropriate scientific education and proven experience will be increasingly needed. A major awareness of professional competency, combined with proactive collaboration with clinicians, will yield larger benefits to patient care in terms of appropriateness, quality, equity and sustainability, and will increase the "value" of the services (VALUE = OUTCOME/COSTS).
In conclusion, these considerations can be summarized by the aphorism "learn from your mistakes". This means that the dark periods may be seen as an encouragement for improving. The most suitable approach entails accurate analysis of the situation, within and outside the laboratory environment, as well as by audits and confront with all stakeholders (clinicians, health service management, patients) and, if necessary, organizational changes. This will be the mainstay for reaching a holistic perspective that will become a cornerstone of patient-centered healthcare and will enable us to anticipate the future needs of healthcare (precision medicine, big data management, etc.).
